Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tomohiro, Katagiri"'
Autor:
Yusuke Iizuka, Tomohiro Katagiri, Kengo Ogura, Minoru Inoue, Ryota Nakashima, Kiyonao Nakamura, Takashi Mizowaki
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract This study aimed to assess recurrence-free survival (RFS) rates and recurrence-related factors of patients who received adjuvant therapy (AT) with radioactive iodine (RAI) for differentiated thyroid cancer (DTC) following thyroidectomy. We e
Externí odkaz:
https://doaj.org/article/e0c7370d7d00484aa3353ac80903c9fe
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract This study aimed to evaluate the feasibility of quantifying iodine-131 (131I) accumulation in scintigraphy images and compare planar and single-photon emission computed tomography (SPECT) images to estimate 131I radioactivity in patients rec
Externí odkaz:
https://doaj.org/article/5bffcf038d474b3db18428feaa78bbf6
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
Abstract Background The risk for radiation necrosis is lower in fractionated stereotactic radiotherapy (SRT) than in conventional radiotherapy, and 13-fraction SRT is our method of choice for the treatment of brain metastases ≥ around 2 cm or patie
Externí odkaz:
https://doaj.org/article/b10bf5ff2acc4414ac053d4b05a97d79
Autor:
Tomohiro Katagiri, Yoshio Ohyama, Hideo Miyamoto, Yuki Egawa, Toshiaki Moriki, Kazuki Hasegawa
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background The prognosis of advanced oral cancer remains dismal. While multimodal therapy is beneficial, maintaining the quality of life of long-term survivors is important. Therefore, risk-adapted treatment regimens need to be designed. We
Externí odkaz:
https://doaj.org/article/8dd37d057d3e4521bd20a815f0a64c12
Autor:
Noriko, Kishi, Yukinori, Matsuo, Takashi, Shintani, Masakazu, Ogura, Takamasa, Mitsuyoshi, Norio, Araki, Kota, Fujii, Setsuko, Okumura, Kiyoshi, Nakamatsu, Takahiro, Kishi, Tomoko, Atsuta, Takashi, Sakamoto, Shuji, Ohtsu, Tomohiro, Katagiri, Masaru, Narabayashi, Satsuki, Fujishiro, Yusuke, Iizuka, Hiroaki, Ozasa, Toyohiro, Hirai, Takashi, Mizowaki
Publikováno v:
Journal of Radiation Research. 64:142-153
Chemoradiotherapy followed by consolidation durvalumab (CCRT+D) improves survival in patients with stage III non-small-cell lung cancer (NSCLC). We compared recurrence patterns and survival in the CCRT+D and CCRT cohorts. We conducted a multicenter,
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
This study aimed to evaluate the feasibility of quantifying iodine-131 (131I) accumulation in scintigraphy images and compare planar and single-photon emission computed tomography (SPECT) images to estimate 131I radioactivity in patients receiving ra
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-7 (2021)
Background The risk for radiation necrosis is lower in fractionated stereotactic radiotherapy (SRT) than in conventional radiotherapy, and 13-fraction SRT is our method of choice for the treatment of brain metastases ≥ around 2 cm or patients who a
Autor:
Kengo Ogura, Masahiro Hiraoka, Nobutaka Mukumoto, Keiichi Takehana, Tomohiro Katagiri, Takashi Mizowaki, Megumi Uto, Mitsuhiro Nakamura, Yuki Miyabe, Hideaki Hirashima
Publikováno v:
Japanese Journal of Radiology. 37:619-625
A new irradiation technique, volumetric-modulated Dynamic WaveArc therapy (VMDWAT), based on sequential non-coplanar trajectories, can be performed using the Vero4DRT. This planning study compared the dose distribution and treatment time between sing
This study aimed to evaluate the feasibility of quantifying iodine-131 (131I) accumulation in scintigraphy images and compare planar and single-photon emission computed tomography (SPECT) images to estimate 131I radioactivity in patients receiving ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf01d77b1293d4c1df17e375f1df1db7
https://doi.org/10.21203/rs.3.rs-278226/v1
https://doi.org/10.21203/rs.3.rs-278226/v1
Autor:
Yoshio Ohyama, Tomohiro Katagiri, Kazuki Hasegawa, Toshiaki Moriki, Yuki Egawa, Hideo Miyamoto
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background The prognosis of advanced oral cancer remains dismal. While multimodal therapy is beneficial, maintaining the quality of life of long-term survivors is important. Therefore, risk-adapted treatment regimens need to be designed. We herein in